Auto-Injector Market Research Report - Global Forecast till 2027

Auto-Injector Market Research Report: By Product Type (Disposable, Reusable), Application (Anaphylaxis, Multiple Sclerosis, Diabetes, Allergies, Rheumatoid Arthritis, Others), Distribution Channel (Online Retailer, Pharmacy, Others), End-User (Home Care Settings, Hospitals & Clinics, Ambulatory Surgical Centers), and Region (Americas, Europe, Asia-Pacific, and Middle East and Africa)—Global Forecast till 2027

ID: MRFR/MED/1514-HCR | February 2021 | Region: Global | 85 pages

Please note that the assessment period of report has been updated from 2019-2025 to 2020-2027. Cordially fill Sample form for the updated data.

Market Scenario


The auto-injector market is expected to grow significantly over the forecast period. The market held an estimated valuation of USD 37.44 million in 2018 and is projected to account for USD 125.32 million by 2025 at a CAGR of ~22.0% over the forecast period.


The increasing availability of generic auto-injectors and the growing geriatric population are likely to drive the growth of the market during the forecast period.


Furthermore, auto-injectors are more effective and less painful in comparison to syringes; these also provide more control and accurate drug delivery as compared to manual injection. These factors also contribute to the growth of the market.


However, the availability of alternatives such as continuous glucose monitoring devices can hinder the market growth over the forecast period.


Segmentation


The auto-injector global market has been segmented based on product type, application, distribution channel, end user, and region.


The auto-injector global market, by product type, has been segmented into disposable and reusable.


On the basis of application, the auto-injector global market has been classified as anaphylaxis, multiple sclerosis, diabetes, allergies, rheumatoid arthritis, and others.


Based on distribution channel, the auto-injector global market has been segmented into online retailer, pharmacy, and rectal.


By end user, the auto-injector global market has been segmented into home care settings, hospitals & clinics, and ambulatory surgical centers.


The auto-injector global market has been studied for the Americas, Europe, Asia-Pacific, and the Middle East and African region.


The Auto-Injector market in the Americas has further been segmented into North America and South America, with the North American market being segmented into the US and Canada.


The European auto-injector market has been divided into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The auto-injector market in Asia-Pacific has been divided into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The auto-injector market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Auto-Injector Market Share (%), by Region, 2018


Sources: MRFR Analysis


The Americas dominated the global auto-injector market owing to the increasing prevalence of anaphylaxis and food allergies, and rapid technological advancements taking place in the healthcare sector in the region.  In 2018, according to the American Academy of Pediatrics, about 7.6%—which is almost 5.6 million children in the US—had food allergies, out of which, less than half had access to epinephrine auto-injector prescription. The most common allergies in food are milk, peanut butter, and shellfish.


In 2018, Europe accounted for the second position in the auto-injector global market. The growing prevalence rate of chronic diseases and increasing investments in research and development (R&D) by private companies is expected to drive the growth of the market. Germany commanded the largest share in the European auto-injectors market.  


Asia-Pacific (APAC) is expected to represent the fastest growth in auto-injector throughout the forecast period due to the growing population and the presence of large diabetic patient pool. Countries in Asia-Pacific are adopting and developing new product designs; this, in turn, fuels the market growth in this region. Moreover, China, India, and Japan are expected to contribute significantly to the market growth.


On the other hand, the Middle East and Africa held the least share in the auto-injector global market due to the poor healthcare infrastructure, especially within the African region.


Key Players


Some of the key players in the global auto-injector market are Bayer AG, Haselmeier, Novartis AG, Owen Mumford Ltd, Becton, Dickinson and Company, AbbVie Inc., Johnson & Johnson, Amgen Inc., Teva Pharmaceuticals USA, Biogen, Eli Lilly and Company, Mylan NV, Ypsomed AG, Merck KGaA, AstraZeneca, and Kaleo, Inc.


Market Segmentation


By Product Type



  • Disposable

  • Reusable


By Application



  • Anaphylaxis

  • Multiple Sclerosis

  • Diabetes

  • Allergies

  • Rheumatoid Arthritis

  • Others


By Distribution Channel



  • Online Retailer

  • Pharmacy

  • Others


By End User



  • Home Care Settings

  • Hospitals & Clinics

  • Ambulatory Surgical Centers


Intended Audience



  • Auto-injectors manufacturing companies

  • Auto-injectors suppliers

  • Health insurance players

  • Healthcare Organizations

  • Healthcare Providers

  • Government organizations

  • Biotechnology Companies

  • Research and Development (R&D) Companies



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 125.32 million (2025)
  CAGR   22.0% (2020-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units    Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   product type, application, distribution channel, end user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Bayer AG, Haselmeier, Novartis AG, Owen Mumford Ltd, Becton, Dickinson and Company, AbbVie Inc., Johnson & Johnson, Amgen Inc., Teva Pharmaceuticals USA, Biogen, Eli Lilly and Company, Mylan NV, Ypsomed AG, Merck KGaA, AstraZeneca, and Kaleo, Inc.
  Key Market Opportunities   availability of alternatives such as continuous glucose monitoring devices
  Key Market Drivers

  • increasing availability of generic auto-injectors
  • growing geriatric population


  • Frequently Asked Questions (FAQ) :


    auto-injector market is projected grow at approximately 22% CAGR during the assessment period (2019-2025).

    The valuation of the global auto-injector market had reached USD 37.44 MN in 2018.

    The valuation of the global auto-injector market is estimated to increase to USD 125.32 MN by the end of 2025.

    North America holds the largest share in the global auto-injector market, followed by Europe and the Asia Pacific, respectively.

    Haselmeier, Bayer AG, Novartis AG, Becton, Dickinson and Company, Owen Mumford Ltd, AbbVie Inc., Amgen Inc., Johnson & Johnson, Teva Pharmaceuticals USA, Eli Lilly and Company, Biogen, Mylan NV, Merck KGaA, Ypsomed AG, Kaleo, Inc., and AstraZeneca, are some of the major players operating in the auto-injector market.

    Table of Contents:

    Chapter 1. Executive Summary

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Overview

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.2.1 R&D and Designing

    5.2.2 Manufacturing

    5.2.3 Distribution & Sales

    5.2.4 Post-Sales Review

    Chapter 6. Global Auto-Injectors Market, by Product Type

    6.1 Overview

    6.2 Disposable

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3 Reusable

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Auto-Injectors Market, by Application

    8.1 Overview

    8.2 Anaphylaxis

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3 Multiple Sclerosis

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4 Diabetes

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.5 Allergies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.6 Rheumatoid Arthritis

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.7 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Auto-Injectors Market, by Distribution Channel

    8.1 Overview

    8.2 Online Retailer

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3 Pharmacy

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 10. Global Auto-Injectors Market, by End User

    10.1 Overview

    10.2 Home Care Settings

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    10.3 Hospitals & Clinics

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    10.4 Ambulatory Surgical Centers

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 11. Global Auto-Injectors Market, by Region

    11.1 Overview

    11.2 Americas

    11.2.1 North America

    11.2.1.1 US

    11.2.1.2 Canada

    11.2.2 Latin America

    11.3 Europe

    11.3.1 Western Europe

    11.3.1.1 Germany

    11.3.1.2 France

    11.3.1.3 Italy

    11.3.1.4 Spain

    11.3.1.5 UK

    11.3.1.6 Rest of Western Europe

    11.3.2 Eastern Europe

    11.4 Asia-Pacific

    11.4.1 Japan

    11.4.2 China

    11.4.3 India

    11.4.4 Australia

    11.4.5 South Korea

    11.4.6 Rest of Asia-Pacific

    11.5 Middle East & Africa

    11.5.1 Middle East

    11.5.2 Africa

    Chapter 12. Company Landscape

    12.1 Overview

    12.2 Competitive Analysis

    Chapter 13. Company Profile

    13.1 Bayer AG

    13.1.1 Company Overview

    13.1.2 Products/Services Offered

    13.1.3 Financial Overview

    13.1.4 Key Developments

    13.1.5 SWOT Analysis

    13.1.6 Key Strategies

    13.2 Haselmeier

    13.2.1 Company Overview

    13.2.2 Products/Services Offered

    13.2.3 Financial Overview

    13.2.4 Key Developments

    13.2.5 SWOT Analysis

    13.2.6 Key Strategies

    13.3 Novartis AG

    13.3.1 Company Overview

    13.3.2 Products/Services Offered

    13.3.3 Financial Overview

    13.3.4 Key Development

    13.3.5 SWOT Analysis

    13.3.6 Key Strategies

    13.4 Owen Mumford Ltd

    13.4.1 Company Overview

    13.4.2 Products/Services Offered

    13.4.3 Financial Overview

    13.4.4 Key Development

    13.4.5 SWOT Analysis

    13.4.6 Key Strategies

    13.5 Becton, Dickinson and Company

    13.5.1 Company Overview

    13.5.2 Products/Services Offered

    13.5.3 Financial overview

    13.5.4 Key Developments

    13.5.5 SWOT Analysis

    13.5.6 Key Strategies

    13.6 AbbVie Inc.

    13.6.1 Company Overview

    13.6.2 Products/Services Offered

    13.6.3 Financial Overview

    13.6.4 Key Developments

    13.6.5 SWOT Analysis

    13.6.6 Key Strategies

    13.7 Johnson & Johnson

    13.7.1 Overview

    13.7.2 Products/Services Offered

    13.7.3 Financial Overview

    13.7.4 Key Developments

    13.7.5 SWOT Analysis

    13.7.6 Key Strategies

    13.8 Amgen Inc.

    13.8.1 Overview

    13.8.2 Products/Services Offered

    13.8.3 Financial Overview

    13.8.4 Key Developments

    13.8.5 SWOT Analysis

    13.8.6 Key Strategies

    13.9 Teva Pharmaceuticals USA

    13.9.1 Overview

    13.9.2 Products/Services Offered

    13.9.3 Financial Overview

    13.9.4 Key Developments

    13.9.5 SWOT Analysis

    13.9.6 Key Strategies

    13.10 Biogen

    13.10.1 Overview

    13.10.2 Products/Services Offered

    13.10.3 Financial Overview

    13.10.4 Key Developments

    13.10.5 SWOT Analysis

    13.10.6 Key Strategies

    13.11 Eli Lilly and Company

    13.11.1 Overview

    13.11.2 Products/Services Offered

    13.11.3 Financial Overview

    13.11.4 Key Developments

    13.11.5 SWOT Analysis

    13.11.6 Key Strategies

    13.12 Mylan N.V.

    13.12.1 Overview

    13.12.2 Products/Services Offered

    13.12.3 Financial Overview

    13.12.4 Key Developments

    13.12.5 SWOT Analysis

    13.12.6 Key Strategies

    13.13 Ypsomed AG

    13.13.1 Overview

    13.13.2 Products/Services Offered

    13.13.3 Financial Overview

    13.13.4 Key Developments

    13.13.5 SWOT Analysis

    13.13.6 Key Strategies

    13.14 Merck KGaA

    13.14.1 Overview

    13.14.2 Products/Services Offered

    13.14.3 Financial Overview

    13.14.4 Key Developments

    13.14.5 SWOT Analysis

    13.14.6 Key Strategies

    13.15 AstraZeneca

    13.15.1 Overview

    13.15.2 Products/Services Offered

    13.15.3 Financial Overview

    13.15.4 Key Developments

    13.15.5 SWOT Analysis

    13.15.6 Key Strategies

    13.16 kaleo, Inc.

    13.16.1 Overview

    13.16.2 Products/Services Offered

    13.16.3 Financial Overview

    13.16.4 Key Developments

    13.16.5 SWOT Analysis

    13.16.6 Key Strategies

    13.13 Others

    Chapter 14 Appendix

    14.1 References

    14.2 Related Reports


    LIST OF TABLES

    Table 1 Global Auto-Injectors Market Synopsis, 2020-2027

    Table 2 Global Auto-Injectors Market Estimates and Forecast, 2020-2027 (USD Million)

    Table 3 Global Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

    Table 4 Global Auto-Injectors Market, by Application, 2020-2027 (USD Million)

    Table 5 Global Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

    Table 6 Global Auto-Injectors Market, by End User, 2020-2027 (USD Million)

    Table 7 Global Auto-Injectors Market, by Region, 2020-2027 (USD Million)

    Table 8 Americas: Auto-Injectors Market, by Region, 2020 and 2025

    Table 9 Americas: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

    Table 10 Americas: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

    Table 11 Americas: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

    Table 12 Americas: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

    Table 13 North America: Auto-Injectors Market, by Country, 2020-2027 (USD Million)

    Table 14 North America: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

    Table 15 North America: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

    Table 16 North America: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

    Table 17 North America: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

    Table 18 US: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

    Table 19 US: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

    Table 20 US: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

    Table 21 US: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

    Table 22 Canada: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

    Table 23 Canada: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

    Table 24 Canada: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

    Table 25 Canada: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

    Table 26 Latin America: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

    Table 27 Latin America: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

    Table 28 Latin America: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

    Table 29 Latin America: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

    Table 30 Europe: Auto-Injectors Market, by Region, 2020-2027 (USD Million)

    Table 31 Europe: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

    Table 32 Europe: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

    Table 33 Europe: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

    Table 34 Europe: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

    Table 35 Western Europe: Auto-Injectors Market, by Country, 2020-2027 (USD Million)

    Table 36 Western Europe: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

    Table 37 Western Europe: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

    Table 38 Western Europe: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

    Table 39 Western Europe: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

    Table 40 Eastern Europe: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

    Table 41 Eastern Europe: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

    Table 42 Eastern Europe: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

    Table 43 Eastern Europe: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

    Table 44 Asia-Pacific: Auto-Injectors Market, by Country, 2020-2027 (USD Million)

    Table 45 Asia-Pacific: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

    Table 46 Asia-Pacific: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

    Table 47 Asia-Pacific: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

    Table 48 Asia-Pacific: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

    Table 49 Middle East & Africa: Auto-Injectors Market, by Region, 2020-2027 (USD Million)

    Table 50 Middle East & Africa: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

    Table 51 Middle East & Africa: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

    Table 52 Middle East & Africa: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

    Table 53 Middle East & Africa: Auto-Injectors Market, by End User, 2020-2027 (USD Million)


    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Market Structure for Global Auto-Injectors Market

    Figure 3 Market Dynamics for Global Auto-Injectors Market

    Figure 4 Global Auto-Injectors Market Share, by Product Type, 2020 (%)

    Figure 5 Global Auto-Injectors Market Share, by Product Type, 2020 (USD Million)

    Figure 6 Global Auto-Injectors Market Share, by Application, 2020 (%)

    Figure 7 Global Auto-Injectors Market Share, by Application, 2020 (USD Million)

    Figure 8 Global Auto-Injectors Market Share, by Distribution Channel, 2020 (%)

    Figure 9 Global Auto-Injectors Market Share, by Distribution Channel, 2020 (USD Million)

    Figure 10 Global Auto-Injectors Market Share, by End User, 2020 (%)

    Figure 11 Global Auto-Injectors Market Share, by End User, 2020 (USD Million)

    Figure 12 Global Auto-Injectors Market Share, by Region, 2020 (%)

    Figure 13 Americas: Auto-Injectors Market Share, by Region, 2020 (%)

    Figure 14 North America: Auto-Injectors Market Share, by Country, 2020 (%)

    Figure 15 Europe: Auto-Injectors Market Share, by Region, 2020 (%)

    Figure 16 Western Europe: Auto-Injectors Market Share, by Country, 2020 (%)

    Figure 17 Asia-Pacific: Auto-Injectors Market Share, by Country, 2020 (%)

    Figure 18 Middle East & Africa: Auto-Injectors Market Share, by Region, 2020 (%)

    Figure 19 Global Auto-Injectors Market: Company Share Analysis, 2020 (%)

    Figure 20 Bayer AG: Key Financials

    Figure 21 Bayer AG: Segmental Revenue

    Figure 22 Bayer AG: Geographical Revenue

    Figure 23 Haselmeier: Key Financials

    Figure 24 Haselmeier: Segmental Revenue

    Figure 25 Haselmeier: Geographical Revenue

    Figure 26 Novartis AG: Key Financials

    Figure 27 Novartis AG: Segmental Revenue

    Figure 28 Novartis AG: Geographical Revenue

    Figure 29 Owen Mumford Ltd: Key Financials

    Figure 30 Owen Mumford Ltd: Segmental Revenue

    Figure 31 Owen Mumford Ltd: Geographical Revenue

    Figure 32 Becton, Dickinson and Company: Key Financials

    Figure 33 Becton, Dickinson and Company: Segmental Revenue

    Figure 34 Becton, Dickinson and Company: Geographical Revenue

    Figure 35 AbbVie Inc.: Key Financials

    Figure 36 AbbVie Inc.: Segmental Revenue

    Figure 37 AbbVie Inc.: Geographical Revenue

    Figure 38 Johnson & Johnson: Key Financials

    Figure 39 Johnson & Johnson: Segmental Revenue

    Figure 40 Johnson & Johnson: Geographical Revenue

    Figure 41 Amgen Inc.: Key Financials

    Figure 42 Amgen Inc.: Segmental Revenue

    Figure 43 Amgen Inc.: Geographical Revenue

    Figure 44 Teva Pharmaceuticals USA: Key Financials

    Figure 45 Teva Pharmaceuticals USA: Segmental Revenue

    Figure 46 Teva Pharmaceuticals USA: Geographical Revenue

    Figure 47 Biogen: Key Financials

    Figure 48 Biogen: Segmental Revenue

    Figure 49 Biogen: Geographical Revenue

    Figure 50 Eli Lilly and Company: Key Financials

    Figure 51 Eli Lilly and Company: Segmental Revenue

    Figure 52 Eli Lilly and Company: Geographical Revenue

    Figure 53 Mylan NV: Key Financials

    Figure 54 Mylan NV: Segmental Revenue

    Figure 55 Mylan NV: Geographical Revenue

    Figure 56 Ypsomed AG: Key Financials

    Figure 57 Ypsomed AG: Segmental Revenue

    Figure 58 Ypsomed AG: Geographical Revenue

    Figure 59 Merck KGaA: Key Financials

    Figure 60 Merck KGaA: Segmental Revenue

    Figure 61 Merck KGaA: Geographical Revenue

    Figure 62 AstraZeneca: Key Financials

    Figure 63 AstraZeneca: Segmental Revenue

    Figure 64 AstraZeneca: Geographical Revenue

    Figure 65 kaleo, Inc.: Key Financials

    Figure 66 kaleo, Inc.: Segmental Revenue

    Figure 67 kaleo, Inc.: Geographical Revenue